Can we use interleukin-1β blockade for lung cancer treatment?
Transl Lung Cancer Res
.
2018 Apr;7(Suppl 2):S160-S164.
doi: 10.21037/tlcr.2018.03.15.
Authors
Adrian Gottschlich
1
,
Stefan Endres
1
,
Sebastian Kobold
1
Affiliation
1
Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
PMID:
29780710
PMCID:
PMC5943222
DOI:
10.21037/tlcr.2018.03.15
No abstract available
Publication types
Editorial
Comment